Add BrightSurf on Google Email

Tips from the American Journal of Pathology

Researchers found that HAART contributes to pulmonary hypertension in HIV-infected patients by impairing blood vessel-lining endothelial cell function. A novel treatment for chronic hypoxic pulmonary hypertension (PHTN) involves neprilysin, which protects against PHTN by regulating neural signaling molecules.

SourceAmerican Journal of Pathology·JournalAmerican Journal Of Pathology·DateFeb 23, 2009

JCI online early table of contents: Dec. 8, 2008

Researchers have developed a mouse model of neonatal diabetes that replicates human disease, providing new insight into the condition. Additionally, studies have identified a link between endothelial dysfunction and altered metabolic responses, particularly in relation to high-fat diets and glucose regulation.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 8, 2008

Cold Spring Harbor Protocols features tissue culture methods for immune cells and neurons

The journal Cold Spring Harbor Protocols presents two articles detailing experimental culture methods for cells from the immune system and the nervous system. These protocols enable researchers to isolate and grow specialized cells like macrophages and cerebellar granule neurons, facilitating studies on their functions and interactions.

SourceCold Spring Harbor Laboratory·JournalCold Spring Harbor Protocols·DateDec 2, 2008

Proteomics study yields clues as to how tuberculosis might be thwarting the immune system

A proteomics study has identified new proteins that facilitate communication between the immune system and the self-cleaning process, potentially leading to new treatments for tuberculosis. The research found that autophagy plays a crucial role in immune response, particularly against intracellular pathogens.

SourceDOE/Lawrence Berkeley National Laboratory·JournalProceedings of the National Academy of Sciences·DateNov 5, 2008

JCI online early table of contents: Sept. 11, 2008

Researchers identified A2BAR as a potential therapeutic target for acute lung injury, which spontaneously resolves in some individuals. Additionally, human immune cells' secreted proteins enhance the clearance of bacteria by other immune cells, offering a new mechanism for bacterial infections.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 11, 2008

Team IDs weakness in anthrax bacteria

Researchers have discovered a weakness in the defenses of the anthrax bacterium that could be exploited to produce new antibiotics. Nitric oxide is a critical part of Bacillus anthracis's defense against the immune response, and disrupting this system could make it vulnerable to attack by macrophages.

SourceMassachusetts Institute of Technology·JournalProceedings of the National Academy of Sciences·DateJan 24, 2008

St. Jude finds link between cellular defense processes, showing how cancer cells survive

Researchers at St. Jude Children's Research Hospital have found a connection between two cellular defense mechanisms, phagocytosis and autophagy, that help the body fight infections and resist chemotherapy drugs. The study suggests that these mechanisms work together to destroy germs and cancer cells, paving the way for new treatments.

New research helps explain how tumors go undetected by the body

Scientists discovered that regulatory T cells can reverse macrophages' role in causing inflammation, allowing tumors to go undetected by the body's natural defenses. This knowledge may lead to new treatments for tumors and could also be applied to block chronic inflammation in conditions like rheumatoid arthritis.

SourceBiotechnology and Biological Sciences Research Council·JournalProceedings of the National Academy of Sciences·DateNov 19, 2007

JCI table of contents -- July 26, 2007

A study published in JCI found that bacteria residing in the gut boost immune response to tumors after total body irradiation, a common treatment for cancer. The researchers discovered that a specific population of bacteria plays a crucial role in augmenting the function of tumor-specific T cells and resulting in tumor regression.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 26, 2007

JCI table of contents: January 2, 2007

A genetic mutation in the beta1-adrenergic receptor alters the response to certain heart failure drugs, highlighting the potential for personalized medicine. The study found that a single amino acid change in the receptor can affect how well patients respond to beta blockers, with some variants showing increased sensitivity to carvedilol.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 2, 2007

JCI table of contents: August 1, 2006

A new study published in the Journal of Clinical Investigation found that marijuana use at conception and early pregnancy can prevent embryos from safely passing to the uterus, leading to early pregnancy failure. The study also showed that THC, a psychoactive component of marijuana, can swamp normal signaling systems, causing implantat...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateAug 1, 2006

UCSB researchers discover shape matters to macrophages

Phagocytosis, a key part of the immune system, depends on macrophages to remove particles from the body. Researchers at UCSB found that particle shape, not size, is more important in this process. This discovery could lead to the design of drug carriers that can be retained by the body for longer periods and vaccines that stimulate rap...

SourceUniversity of California - Santa Barbara·JournalProceedings of the National Academy of Sciences·DateMar 21, 2006

JCI table of contents November, 2005

Researchers pinpoint CD36 as the first candidate for detecting fatty acids in the oral cavity, influencing digestive physiology and potentially increasing obesity risk. The study also reveals an alteration in the fat perception system may impact HIV transmission through human milk.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateOct 20, 2005

JCI table of contents September 1, 2005

Researchers have discovered a novel Group B Streptococcus (GBS) gene, iagA, that helps the bacteria invade the human blood-brain barrier, leading to meningitis. A glycolipid treatment has been found to induce long-term anergy in natural killer T cells, which could impact its use as an immune activator.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 1, 2005

Growing lymph vessels with macrophages? Surprisingly, yes!

Researchers discovered that CD11b-positive macrophages play a crucial role in the development of lymphangiogenesis in the cornea during inflammatory conditions. These macrophages transform into endothelial cells or stimulate the division of existing lymphatic cells, leading to the formation of new lymph vessels.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 1, 2005